Literature DB >> 19104150

Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1.

Katharina Eikermann-Haerter1, Ergin Dileköz, Chiho Kudo, Sean I Savitz, Christian Waeber, Michael J Baum, Michel D Ferrari, Arn M J M van den Maagdenberg, Michael A Moskowitz, Cenk Ayata.   

Abstract

Familial hemiplegic migraine type 1 (FHM1) is an autosomal dominant subtype of migraine with aura that is associated with hemiparesis. As with other types of migraine, it affects women more frequently than men. FHM1 is caused by mutations in the CACNA1A gene, which encodes the alpha1A subunit of Cav2.1 channels; the R192Q mutation in CACNA1A causes a mild form of FHM1, whereas the S218L mutation causes a severe, often lethal phenotype. Spreading depression (SD), a slowly propagating neuronal and glial cell depolarization that leads to depression of neuronal activity, is the most likely cause of migraine aura. Here, we have shown that transgenic mice expressing R192Q or S218L FHM1 mutations have increased SD frequency and propagation speed; enhanced corticostriatal propagation; and, similar to the human FHM1 phenotype, more severe and prolonged post-SD neurological deficits. The susceptibility to SD and neurological deficits is affected by allele dosage and is higher in S218L than R192Q mutants. Further, female S218L and R192Q mutant mice were more susceptible to SD and neurological deficits than males. This sex difference was abrogated by ovariectomy and senescence and was partially restored by estrogen replacement, implicating ovarian hormones in the observed sex differences in humans with FHM1. These findings demonstrate that genetic and hormonal factors modulate susceptibility to SD and neurological deficits in FHM1 mutant mice, providing a potential mechanism for the phenotypic diversity of human migraine and aura.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19104150      PMCID: PMC2613474          DOI: 10.1172/JCI36059

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  95 in total

1.  Facilitation of Leao's spreading depression by a pyrrolopyrimidine derivative.

Authors:  B DeLuca; M Shibata; G Brozek; J Bures
Journal:  Neuropharmacology       Date:  1975-08       Impact factor: 5.250

2.  Minor head trauma-induced sporadic hemiplegic migraine coma.

Authors:  Robert P Curtain; Robert L Smith; Mick Ovcaric; Lyn R Griffiths
Journal:  Pediatr Neurol       Date:  2006-04       Impact factor: 3.372

3.  Voltage-activated Ca(2+) channels and their role in the endocrine function of the pituitary gland in newborn and adult mice.

Authors:  Simon Sedej; Tetsuhiro Tsujimoto; Robert Zorec; Marjan Rupnik
Journal:  J Physiol       Date:  2004-01-14       Impact factor: 5.182

4.  The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel.

Authors:  A Ducros; C Denier; A Joutel; M Cecillon; C Lescoat; K Vahedi; F Darcel; E Vicaut; M G Bousser; E Tournier-Lasserve
Journal:  N Engl J Med       Date:  2001-07-05       Impact factor: 91.245

5.  Immunoreactivity to neurofilaments in the rodent anterior pituitary is associated with the expression of alpha 1A protein subunits of voltage-gated Ca2+ channels.

Authors:  T Fiordelisio; N Jiménez; S Baba; K Shiba; A Hernández-Cruz
Journal:  J Neuroendocrinol       Date:  2007-11       Impact factor: 3.627

6.  Altered profiles of estradiol and progesterone associated with prolonged estrous cycles and persistent vaginal cornification in aging C57BL/6J mice.

Authors:  J F Nelson; L S Felicio; H H Osterburg; C E Finch
Journal:  Biol Reprod       Date:  1981-05       Impact factor: 4.285

7.  The value of ultramicro-analysis of lactic acid in tracing the penetration of Leão's cortical spreading depression to subcortical areas.

Authors:  J Krivánek; E Fifková
Journal:  J Neurol Sci       Date:  1965 Jul-Aug       Impact factor: 3.181

8.  Epilepsy as part of the phenotype associated with ATP1A2 mutations.

Authors:  Liesbet Deprez; Sarah Weckhuysen; Katelijne Peeters; Tine Deconinck; Kristl G Claeys; Lieve R F Claes; Arvid Suls; Tine Van Dyck; André Palmini; Gert Matthijs; Wim Van Paesschen; Peter De Jonghe
Journal:  Epilepsia       Date:  2007-11-19       Impact factor: 5.864

9.  Estrogen is neuroprotective via an apolipoprotein E-dependent mechanism in a mouse model of global ischemia.

Authors:  Karen Horsburgh; I Mhairi Macrae; Hilary Carswell
Journal:  J Cereb Blood Flow Metab       Date:  2002-10       Impact factor: 6.200

10.  Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women.

Authors:  F Granella; G Sances; C Zanferrari; A Costa; E Martignoni; G C Manzoni
Journal:  Headache       Date:  1993 Jul-Aug       Impact factor: 5.887

View more
  98 in total

1.  Migraine mutations increase stroke vulnerability by facilitating ischemic depolarizations.

Authors:  Katharina Eikermann-Haerter; Jeong Hyun Lee; Izumi Yuzawa; Christina H Liu; Zhipeng Zhou; Hwa Kyoung Shin; Yi Zheng; Tao Qin; Tobias Kurth; Christian Waeber; Michel D Ferrari; Arn M J M van den Maagdenberg; Michael A Moskowitz; Cenk Ayata
Journal:  Circulation       Date:  2011-12-05       Impact factor: 29.690

2.  Enhanced subcortical spreading depression in familial hemiplegic migraine type 1 mutant mice.

Authors:  Katharina Eikermann-Haerter; Izumi Yuzawa; Tao Qin; Yumei Wang; Kwangyeol Baek; Young Ro Kim; Ulrike Hoffmann; Ergin Dilekoz; Christian Waeber; Michel D Ferrari; Arn M J M van den Maagdenberg; Michael A Moskowitz; Cenk Ayata
Journal:  J Neurosci       Date:  2011-04-13       Impact factor: 6.167

Review 3.  Menstrual migraine: what it is and does it matter?

Authors:  Letizia Maria Cupini; Ilenia Corbelli; Paola Sarchelli
Journal:  J Neurol       Date:  2020-01-28       Impact factor: 4.849

4.  Migraine mutations impair hippocampal learning despite enhanced long-term potentiation.

Authors:  Ergin Dilekoz; Thijs Houben; Katharina Eikermann-Haerter; Mustafa Balkaya; A Mariette Lenselink; Michael J Whalen; Sabine Spijker; Michel D Ferrari; Arn M J M van den Maagdenberg; Cenk Ayata
Journal:  J Neurosci       Date:  2015-02-25       Impact factor: 6.167

5.  The first phase of a migraine attack resides in the cortex.

Authors:  Hayrunnisa Bolay
Journal:  J Neural Transm (Vienna)       Date:  2012-03-18       Impact factor: 3.575

6.  Abnormal synaptic Ca(2+) homeostasis and morphology in cortical neurons of familial hemiplegic migraine type 1 mutant mice.

Authors:  Katharina Eikermann-Haerter; Michal Arbel-Ornath; Nilufer Yalcin; Esther S Yu; Kishore V Kuchibhotla; Izumi Yuzawa; Eloise Hudry; Carli R Willard; Mihail Climov; Fatmagul Keles; Arianna M Belcher; Buse Sengul; Andrea Negro; Isaac A Rosen; Andrea Arreguin; Michel D Ferrari; Arn M J M van den Maagdenberg; Brian J Bacskai; Cenk Ayata
Journal:  Ann Neurol       Date:  2015-07-06       Impact factor: 10.422

Review 7.  Calcium channels and synaptic transmission in familial hemiplegic migraine type 1 animal models.

Authors:  Osvaldo D Uchitel; Carlota González Inchauspe; Mariano N Di Guilmi
Journal:  Biophys Rev       Date:  2013-12-03

8.  Brainstem spreading depolarization and cortical dynamics during fatal seizures in Cacna1a S218L mice.

Authors:  Inge C M Loonen; Nico A Jansen; Stuart M Cain; Maarten Schenke; Rob A Voskuyl; Andrew C Yung; Barry Bohnet; Piotr Kozlowski; Roland D Thijs; Michel D Ferrari; Terrance P Snutch; Arn M J M van den Maagdenberg; Else A Tolner
Journal:  Brain       Date:  2019-02-01       Impact factor: 13.501

Review 9.  Cortical spreading depression and migraine.

Authors:  Andrew C Charles; Serapio M Baca
Journal:  Nat Rev Neurol       Date:  2013-09-17       Impact factor: 42.937

10.  Heterogeneous incidence and propagation of spreading depolarizations.

Authors:  Dan Kaufmann; Jeremy J Theriot; Jekaterina Zyuzin; C Austin Service; Joshua C Chang; Y Tanye Tang; Vladimir B Bogdanov; Sylvie Multon; Jean Schoenen; Y Sungtaek Ju; K C Brennan
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.